Somtochukwu S. Onwah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Somtochukwu S. Onwah has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Enitan S. Salako
Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
2 shared publications - Jude Ezeh Uzonna
Department of Immunology, Max Rady College of Medicine, University of Manitoba
2 shared publications - Romaniya Zayats
Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
2 shared publications - Thomas T. Murooka
Department of Medical Microbiology and Infectious Diseases, Faculty of Health SciencesUniversity of Manitoba, Canada
2 shared publications - Abdelillah Soussi Gounni
Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
1 shared publication Aida Feiz-Barazandeh
Department of Immunology, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba R3E 0T5
1 shared publication
Latest Publications
- Open Access
- 6 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (10) , eaeb3345
Persistent antigen is essential for sustaining Leishmania major –specific memory CD4 + T cells and long-term immunity
Memory CD4 + T cells are central to long-term immunity, yet their persistence in the absence of antigen remains controversial. Lifelong immunity following cutaneous leishmaniasis is primarily mediated by CD4 + T cells, but whether persistent parasites are required for sustaining this immunity has not been empirically established. Using a nonpersistent Leishmania major strain ( dhfr-ts –deficient), we demonstrate that loss of antigen leads to a decline in Leishmania -specific CD4 + T cells and susceptibility to reinfection. To elucidate the mechanism, we developed Leishmania phosphoenolpyruvate carboxykinase (PEPCK)-specific CD4 + T cell receptor transgenic (PEG) mice, enabling precise tracking of Leishmania -specific memory CD4 + T cells. Both in vitro and in vivo–generated memory PEG cells progressively declined in the absence of antigen, independent of major histocompatibility complex II expression. Mice infected with PEPCK antigen–deficient L. major failed to sustain recall responses and secondary immunity. These findings in a L. major model system argue that persistent antigen may be indispensable for maintaining memory CD4 + T cells and ensuring durable immunity against chronic infections.
- 6 March 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (10) , eaeb3345
Open AccessPersistent antigen is essential for sustaining Leishmania major –specific memory CD4 + T cells and long-term immunity
Memory CD4 + T cells are central to long-term immunity, yet their persistence in the absence of antigen remains controversial. Lifelong immunity following cutaneous leishmaniasis is primarily mediated by CD4 + T cells, but whether persistent parasites are required for sustaining this immunity has not been empirically established. Using a nonpersistent Leishmania major strain ( dhfr-ts –deficient), we demonstrate that loss of antigen leads to a decline in Leishmania -specific CD4 + T cells and susceptibility to reinfection. To elucidate the mechanism, we developed Leishmania phosphoenolpyruvate carboxykinase (PEPCK)-specific CD4 + T cell receptor transgenic (PEG) mice, enabling precise tracking of Leishmania -specific memory CD4 + T cells. Both in vitro and in vivo–generated memory PEG cells progressively declined in the absence of antigen, independent of major histocompatibility complex II expression. Mice infected with PEPCK antigen–deficient L. major failed to sustain recall responses and secondary immunity. These findings in a L. major model system argue that persistent antigen may be indispensable for maintaining memory CD4 + T cells and ensuring durable immunity against chronic infections.
- 1 February 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (3) , 588-598
Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response
Protective immunity to cutaneous leishmaniasis is mediated by IFN-γ–secreting CD4+ Th1 cells. IFN-γ binds to its receptor on Leishmania-infected macrophages, resulting in their activation, production of NO, and subsequent destruction of parasites. This study investigated the role of Semaphorin 3E (Sema3E) in host immunity to Leishmania major infection in mice. We observed a significant increase in Sema3E expression at the infection site at different timepoints following L. major infection. Sema3E-deficient (Sema3E knockout [KO]) mice were highly resistant to L. major infection, as evidenced by significantly (p < 0.05–0.01) reduced lesion sizes and lower parasite burdens at different times postinfection when compared with their infected wild-type counterpart mice. The enhanced resistance of Sema3E KO mice was associated with significantly (p < 0.05) increased IFN-γ production by CD4+ T cells. CD11c+ cells from Sema3E KO mice displayed increased expression of costimulatory molecules and IL-12p40 production following L. major infection and were more efficient at inducing the differentiation of Leishmania-specific CD4+ T cells to Th1 cells than their wild-type counterpart cells. Furthermore, purified CD4+ T cells from Sema3E KO mice showed increased propensity to differentiate into Th1 cells in vitro, and this was significantly inhibited by the addition of recombinant Sema3E in vitro. These findings collectively show that Sema3E is a negative regulator of protective CD4+ Th1 immunity in mice infected with L. major and suggest that its neutralization may be a potential therapeutic option for treating individuals suffering from cutaneous leishmaniasis. Key Points Sema3E suppresses CD11C+ cells and T cell functions during L. major infection. The deficiency of Sema3E leads to enhanced resistance to L. major infection. Visual Abstract
- 1 February 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (3) , 588-598
Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response
Protective immunity to cutaneous leishmaniasis is mediated by IFN-γ–secreting CD4+ Th1 cells. IFN-γ binds to its receptor on Leishmania-infected macrophages, resulting in their activation, production of NO, and subsequent destruction of parasites. This study investigated the role of Semaphorin 3E (Sema3E) in host immunity to Leishmania major infection in mice. We observed a significant increase in Sema3E expression at the infection site at different timepoints following L. major infection. Sema3E-deficient (Sema3E knockout [KO]) mice were highly resistant to L. major infection, as evidenced by significantly (p < 0.05–0.01) reduced lesion sizes and lower parasite burdens at different times postinfection when compared with their infected wild-type counterpart mice. The enhanced resistance of Sema3E KO mice was associated with significantly (p < 0.05) increased IFN-γ production by CD4+ T cells. CD11c+ cells from Sema3E KO mice displayed increased expression of costimulatory molecules and IL-12p40 production following L. major infection and were more efficient at inducing the differentiation of Leishmania-specific CD4+ T cells to Th1 cells than their wild-type counterpart cells. Furthermore, purified CD4+ T cells from Sema3E KO mice showed increased propensity to differentiate into Th1 cells in vitro, and this was significantly inhibited by the addition of recombinant Sema3E in vitro. These findings collectively show that Sema3E is a negative regulator of protective CD4+ Th1 immunity in mice infected with L. major and suggest that its neutralization may be a potential therapeutic option for treating individuals suffering from cutaneous leishmaniasis. Key Points Sema3E suppresses CD11C+ cells and T cell functions during L. major infection. The deficiency of Sema3E leads to enhanced resistance to L. major infection. Visual Abstract